Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Reunion Neuroscience Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Reunion Neuroscience Inc market cap is $13.12M.
What is the 52-week high for Reunion Neuroscience Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Reunion Neuroscience Inc 52 week high is $22.00 as of September 06, 2025.
What is the 52-week low for Reunion Neuroscience Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Reunion Neuroscience Inc 52 week low is $0.6303 as of September 06, 2025.
What is Reunion Neuroscience Inc stock price today?
Reunion Neuroscience Inc stock price today is $1.13.
What was Reunion Neuroscience Inc stock price yesterday?
Reunion Neuroscience Inc stock price yesterday was $1.12.
What is the PE ratio of Reunion Neuroscience Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Reunion Neuroscience Inc’s P/E ratio is -0.35.
What is the Price-to-Book ratio of Reunion Neuroscience Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Reunion Neuroscience Inc P/B ratio is 0.8340.
What is Reunion Neuroscience Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Reunion Neuroscience Inc's EBITDA is 0.64.
What is the 50-day moving average of Reunion Neuroscience Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Reunion Neuroscience Inc 50-day moving average is $1.04.
